🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the dosages of recombinant human s...
Status
Completed
Location
Beijing YouAn Hospital, Capital Medical University
Start Date
2016-04-07
Trial ID
NCT02781753
Treatments Being Tested
This is a phase 3, randomized, multi-center study to evaluate the efficacy ...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2007-02
Trial ID
NCT00411385
Treatments Being Tested
This study will determine if Albumin-linked interferon (Albinterferon alfa-...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-06-18
Trial ID
NCT00489385
Treatments Being Tested
This study will evaluate safety, tolerability, pharmacokinetics and pharmac...
Status
Completed
Location
Novartis Pharmaceuticals, Japan
Start Date
2008-07
Trial ID
NCT00724776
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of Albufero...
Status
Completed
Location
Royal Prince Alfred Hospital
Start Date
2005-05
Trial ID
NCT00115908
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
U.T. M.D. Anderson Cancer Center
Start Date
2009-09
Trial ID
NCT00970996
Treatments Being Tested
This study will evaluate the safety and efficacy of alb-interferon in adult...
Status
Completed
Location
Novartis Investigative site
Start Date
2008-10
Trial ID
NCT00759200
The purpose of this study is to evaluate the dosages of recombinant human s...
Status
Completed
Location
Beijing YouAn Hospital, Capital Medical University
Start Date
2017-06-13
Trial ID
NCT03294798
Treatments Being Tested
This is a phase 3, randomized, multi-center study to evaluate the efficacy ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-12
Trial ID
NCT00402428
Treatments Being Tested